E-DRUG: community surveillance of antimicrobial use and resistance
------------------------------------------------------------------
Dear e-Druggers,
The following WHO publication has just come out and can be accessed at:
http://www.who.int/medicines/publications/who_emp_2009.2/en/index.html
Community-based surveillance of antimicrobial use and resistance in resources-constrained settings: report on five pilot projects, WHO/EMP/MAR/2009.2
Integrated surveillance of antimicrobial resistance and use at all levels of health care is an essential component of any programme to contain antimicrobial resistance. There is currently no standard methodology for conducting community-based surveillance in resource-constrained settings. This document describes five pilot surveillance projects that were set up in India (3 sites) and South Africa (2 sites) with the aim of developing a model for undertaking integrated community-based surveillance in resource-constrained settings and generating baseline data. The methodology used in each area aimed to collect antimicrobial resistance (AMR) and use data from the same geographical area over time, but was modified to suit the particular characteristics of each site. Lessons learned are discussed ....
All other new publications can be viewed at:
http://www.who.int/medicines/publications/Medicinespubarchive/en/index.htmlhttp://www.who.int/medicines/publications/Medicinespubarchive/en/index.html
Best Wishes
Kathleen Holloway
Medical Officer for Medicines Access and Rational Use
Department of Essential Medicines and Pharmaceutical Policy
World Health Organisation, 20 Avenue Appia, Genève, CH-1211
Tel: +41 22 791 2336; Fax: +41 22 791 4167
Email: hollowayk@who.int